Revenue YoY
+9.93%
Operating Income YoY
+35.53%
Net Income YoY
+33.70%
Net Margin Δ
+306 bps
Net income bridge for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $2.62B+33.70%
Profit bridge breakdown for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $7.77B | — |
| Revenue | $5.46B | +208.5% |
| Cost of Revenue | -$840M | -32.1% |
| Operating Expenses | -$864M | -33.0% |
| Other Income / Expense | -$132M | -5.0% |
| Income Tax | -$1.01B | -38.6% |
| Net Income | $10.4B | — |
- Prior Net Income$7.77B
- Revenue$5.46B
- Cost of Revenue-$840M
- Operating Expenses-$864M
- Other Income / Expense-$132M
- Income Tax-$1.01B
- Net Income$10.4B
Identity residual: $6M (delta between driver sum and reported ΔNI)
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.14% TTM
- Dividend Profile1.89% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.